超声引导下射频消融治疗有症状的良性甲状腺结节——英国初步经验
英国首个报告队列回顾性分析19个月内46例患者50个结节,超声引导下射频消融治疗有症状良性甲状腺结节及自主功能性甲状腺结节,无并发症;1个月平均体积缩小53±14.9%(p<0.0001),6个月31个结节平均缩小67±17.6%(p<0.0001);6例自主功能性结节中5例术后1个月甲状腺功能正常,3例6个月时仍正常;甲状腺相关生活质量与美容评分改善。
要点
- 射频消融治疗有症状良性甲状腺结节1个月平均体积缩小53±14.9%,6个月平均缩小67±17.6%。
- 46例患者50个结节治疗无并发症,支持日间射频消融的安全性。
- 6例自主功能性甲状腺结节中5例术后1个月甲状腺功能正常,有6个月数据的3例均维持正常。
核心结论
- 结果与已发表数据一致,提示射频消融可有效缩小结节体积并治疗自主功能性甲状腺结节,且改善甲状腺相关生活质量与美容评分。
研究设计与样本
- 回顾性研究,英国首个报告队列,19个月内46例患者50个结节,治疗前及治疗后1个月、6个月评估结节体积、美容评分和甲状腺相关生活质量评分,自主功能性甲状腺结节患者在三个时间点记录甲状腺功能检查。
诊断标准与关键数值
- 治疗后1个月平均体积缩小53±14.9%(p<0.0001)。
- 有6个月数据的31个结节平均体积缩小67±17.6%(p<0.0001)。
- 6例自主功能性甲状腺结节中5例术后1个月甲状腺功能正常,有6个月数据的3例均维持正常。
- 治疗前82%的结节在静息时清晰可见,治疗后6个月降至12.5%(p<0.0001)。
- 23例患者治疗前与治疗后6个月数据可用,生活质量评分显著降低(p<0.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To report on the use of RFA for the treatment of symptomatic benign and autonomously functioning thyroid nodules (AFTNs) in the first reported UK cohort.
METHODS: Patients treated over a 19-month period were retrospectively reviewed. Nodules were assessed pre-treatment and at 1 and 6 months post-treatment. Nodule volume was calculated and cosmetic assessment and thyroid-related quality of life (QoL) scores were recorded at each time point. Thyroid function tests (TFTs) were recorded at all three time points for patients with ATFNs.
RESULTS: 46 patients with 50 nodules were treated with no complications. The mean volume reduction 1-month post-treatment was 53 +- 14.9 % ( p < 0.0001). Six month data was available for 31 nodules and showed a mean 67 +- 17.6% vol reduction ( p < 0.0001). Five of the six patients with ATFNs were euthyroid at 1-month post-procedure. 6-month data was available on three of these patients, and all remained euthyroid. The thyroid-related QoL and cosmetic scores also improved. Data from 23 patients was available pre-treatment and at 6 months post-treatment and there was a significant ( p < 0.0001) reduction in QoL score. Pre-treatment, 82 % of nodules were readily visible at rest, decreasing to 12.5 % 6 months after treatment ( p < 0.0001).
CONCLUSIONS: Results align with published data suggesting that RFA is effective at reducing nodule volume and at treating ATFNs and leads to improvement in thyroid-related QoL and cosmetic scores.
ADVANCES IN KNOWLEDGE: This early UK experience demonstrates that day-case radiofrequency ablation can provide safe and effective treatment of benign symptomatic thyroid nodules.
引用
- Jawad S, Morley S, Otero S, et al. Ultrasound-guided radiofrequency ablation (RFA) of benign symptomatic thyroid nodules - initial UK experience. Br J Radiol. 2019. PMID: 31084496. doi:10.1259/bjr.20190026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。